The Roles of Tissue Factor in Malignant Gliomas

This study has been completed.
Sponsor:
Collaborator:
Ontario Cancer Research Network
Information provided by:
Ontario Clinical Oncology Group (OCOG)
ClinicalTrials.gov Identifier:
NCT00201903
First received: September 13, 2005
Last updated: May 18, 2007
Last verified: May 2007

September 13, 2005
May 18, 2007
January 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00201903 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Roles of Tissue Factor in Malignant Gliomas
The Roles of Tissue Factor in Malignant Gliomas

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
  • Venous Thromboembolism
  • Brain Tumors
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
October 2006
Not Provided

Inclusion Criteria:

  • participation in PRODIGE
  • adult patients
  • newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas
  • undergone craniotomy or stereotactic biopsy > 2 days and < 4 weeks before

Exclusion Criteria:

  • have known hereditary thrombophilia
  • are receiving experimental antiangiogenic therapy
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States,   Canada
 
NCT00201903
OCOG-2003-TFsubstudy
Yes
Not Provided
Ontario Clinical Oncology Group (OCOG)
Ontario Cancer Research Network
Study Chair: Agnes Lee, MD Hamilton Health Sciences and McMaster University
Principal Investigator: William Geerts, MD Sunnybrook Health Sciences Centre
Principal Investigator: Mark Levine, MD Ontario Clinical Oncology Group (OCOG)
Principal Investigator: James Perry, MD Toronto Sunnybrook Regional Cancer Centre
Principal Investigator: Janusz Rak Hamilton Health Sciences and McMaster University
Principal Investigator: Jeffrey Weitz, MD Hamilton Health Sciences and McMaster University
Ontario Clinical Oncology Group (OCOG)
May 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP